This article discusses published research on a controlled substance. It is not medical advice and not an encouragement to use anything. DMT is illegal in most jurisdictions, and psychedelics carry real psychiatric risk, particularly for anyone with a personal or family history of psychosis.
N,N-Dimethyltryptamine – DMT, the compound Rick Strassman’s book made famous as the spirit molecule – is a simple molecule. It is close enough to serotonin that you could sketch the difference in a few seconds: a tryptamine backbone with two methyl groups on the nitrogen.
It occurs in hundreds of plant species. It is the active compound in ayahuasca, used in Amazonian ceremonial practice for centuries. It is also — and this is the part that generates most of the interest — present in mammalian brain tissue, including human.
That last fact is real and has been measured. What it means is where the argument starts, and almost everything written about it overstates one side or the other.
What Is DMT?
DMT is a tryptamine psychedelic that acts primarily as an agonist at serotonin 5-HT2A receptors — the same primary target as psilocybin and LSD. It also binds the sigma-1 receptor, which is unusual and not fully understood.
Taken by inhalation or injection, its effects are extremely fast and extremely short: onset within seconds, peak at two to five minutes, and largely over within fifteen to thirty minutes. Orally it is destroyed by monoamine oxidase in the gut, which is why ayahuasca combines a DMT-containing plant with a MAO inhibitor from the Banisteriopsis caapi vine.
That combination is worth pausing on. Two plants, neither active alone for this purpose, which together produce an orally active preparation. Amazonian peoples arrived at it from a flora containing tens of thousands of species, without chemistry. How is a genuine open question in ethnobotany.
The Endogenous DMT Story
Here is the chain of evidence, in order, with what each step actually established.
1965-1970s: DMT found in human fluids. Researchers detected DMT in human blood and urine. This established that the body contains it, but not where it came from — diet and gut bacteria were plausible sources.
1990-1995: Strassman’s clinical trials. Psychiatrist Rick Strassman ran the first US human psychedelic study in two decades, administering DMT to 60 volunteers at the University of New Mexico. His book DMT: The Spirit Molecule (2001) reported the results and proposed a hypothesis: that the pineal gland produces DMT and releases it at birth, at death, and during mystical or near-death states.
It is important to be precise here, because Strassman himself was. He presented this as a speculation to be tested, not a finding, and said so explicitly in the book. The certainty was added by everyone who came after.
2013: DMT found in the rat pineal. A study by Barker, Borjigin, Lomnicka and Strassman used microdialysis and LC/MS/MS to sample directly from the pineal gland of living rats, and detected DMT. This was the first direct demonstration that the pineal contains it.
2019: DMT found beyond the pineal, and it spikes at death. A study in Scientific Reports from Borjigin’s lab at Michigan found that rat brains produce DMT in multiple regions, including the neocortex and hippocampus — and, critically, that levels persisted after the pineal gland was removed. The pineal is not the source, or not the only one. The study also reported DMT concentrations rising following induced cardiac arrest.
What This Does and Does Not Show
Established:
- Mammalian brains synthesise DMT. The enzymes required — INMT and AADC — are present in brain tissue.
- Production is not confined to the pineal gland.
- Levels rise in rats following cardiac arrest.
Not established:
- That endogenous concentrations in humans are anywhere near high enough to produce psychedelic effects.
- That DMT is released at birth or death in humans.
- That DMT causes near-death experiences.
The quantitative problem is the serious objection, and pharmacologist David Nichols laid it out in a 2018 paper in the Journal of Psychopharmacology that anyone interested in this should read.
His argument: the measured concentrations of endogenous DMT are on the order of nanomolar — vastly below the levels required at 5-HT2A receptors to produce an effect. A psychoactive dose is milligrams delivered rapidly. The pineal gland weighs roughly 0.1 grams and would need to produce, in Nichols’ estimate, something like 25 mg of DMT in a very short window — far beyond any plausible synthetic capacity for a gland that size, which is primarily occupied making melatonin.
There is also a competition problem. DMT would have to outcompete serotonin at the same receptors, and serotonin is present at far higher concentrations.
The honest position, then: the molecule is there, the machinery is there, and the quantities appear to be far too low to matter. Unless there is a mechanism nobody has found — local concentration at synapses, storage in vesicles, release in bursts too brief to catch — the “spirit molecule” hypothesis does not have the pharmacology behind it.
Borjigin’s own position is notably more cautious than the popular version of her findings.
The Near-Death Experience Link
The 2019 finding that DMT rises after cardiac arrest in rats is the strongest thread connecting DMT to near-death experiences, and it deserves care.
What supports the link: DMT experiences and NDE reports share features — a sense of entering another realm, encounters with apparently autonomous beings, ineffability, and a lasting conviction that the experience was more real than ordinary waking life. A 2018 study by Timmermann and colleagues at Imperial College found that DMT scores on a standard NDE scale overlapped substantially with actual near-death reports.
What weakens it: the rat data does not establish human release at death. The concentrations issue applies with full force. And NDEs occur in circumstances without cardiac arrest at all — fainting, extreme fear, childbirth — where no such surge would be expected.
Why the Experience Is So Consistent
Setting aside the endogenous question, one feature of high-dose DMT is genuinely strange and does not depend on any contested claim: the consistency of the reports.
Users across cultures, with no shared expectations, describe structurally similar content — a rapid passage or breakthrough, an apparently inhabited space, and encounters with entities that appear to have their own agenda and to be aware of the observer. The phenomenology has been catalogued in survey work by Johns Hopkins and Imperial College, and the convergence is measurable.
There are two readings, and neither is currently testable.
The neurological reading. A drug acting on the same receptor system in brains built to the same plan will produce similar output. Visual cortex under specific disruption generates characteristic geometry — the form constants described by Heinrich Klüver in the 1920s, which recur across hallucinogens, migraine aura and pressure phosphenes. Entity encounters may reflect the brain’s very strong bias toward detecting agents, running without normal sensory input to constrain it.
The realist reading. The experience is what it reports itself to be — perception of something ordinarily filtered out.
The second is not a scientific hypothesis in its current form, because no one has proposed a test that could distinguish it from the first. That is a genuine limitation rather than a dismissal: an untestable claim is not necessarily false, but it is not evidence either.
What Is Actually Worth Attention
Three things here are solid and interesting without any of the contested material:
Ayahuasca is a pharmacological achievement. Two plants from an enormous flora, combined to solve a bioavailability problem that was not formally understood until the twentieth century. However it was arrived at, it works — and it is the same category of thing as a breeding programme run on invisible carriers or a self-healing concrete recipe: a working procedure without the theory that explains it.
Psychedelic clinical research is producing real results. Trials of psilocybin for treatment-resistant depression and for end-of-life distress have shown meaningful effects. This is mainstream, regulated, published research, and it is the most consequential development in the field.
The brain makes psychedelics at all. Whatever the amounts, the fact that mammalian neurons contain the enzymatic machinery to synthesise a potent 5-HT2A agonist is a real and unexplained feature of our biology. Nobody has established what it is for.
That last point is the honest version of the mystery. Not “the pineal floods you with DMT when you die,” which the pharmacology does not support — but “your neurons build this molecule and we do not know why.”
Frequently Asked Questions
What is DMT?
N,N-Dimethyltryptamine, a tryptamine psychedelic acting mainly at serotonin 5-HT2A receptors. It occurs in hundreds of plant species, is the active compound in ayahuasca, and is present in mammalian brain tissue.
Does the human brain produce DMT?
Mammalian brains do synthesise DMT, and the enzymes required are present in brain tissue. A 2019 study found production in the neocortex and hippocampus that continued after the pineal gland was removed, so the pineal is not the sole source.
Is DMT the spirit molecule?
That hypothesis came from Rick Strassman, who proposed it explicitly as a speculation to be tested. Pharmacologist David Nichols argued in 2018 that measured endogenous concentrations are nanomolar — far below the levels needed to produce psychedelic effects.
Does DMT cause near-death experiences?
Unproven. DMT levels rose after induced cardiac arrest in rats, and DMT experiences score similarly to NDEs on standard scales. But the human release has not been demonstrated, concentrations appear far too low, and NDEs occur in situations without cardiac arrest.
Why does ayahuasca need two plants?
DMT taken orally is broken down by monoamine oxidase in the gut. Ayahuasca combines a DMT-containing plant with the Banisteriopsis caapi vine, which supplies monoamine oxidase inhibitors and makes the DMT orally active.
How long does DMT last?
Inhaled or injected, effects begin within seconds, peak at roughly two to five minutes, and are largely over within fifteen to thirty minutes. Ayahuasca, taken orally with an MAO inhibitor, lasts several hours.
Why do DMT experiences seem so similar between people?
The convergence is documented. One explanation is neurological: a drug acting on the same receptors in similarly built brains produces similar output, including the geometric form constants Klüver catalogued in the 1920s. Another takes the reports at face value. Neither is currently testable against the other.
Was DMT found in the pineal gland?
Yes. A 2013 study using microdialysis detected DMT directly in the pineal gland of living rats. Later work showed production is not limited to the pineal.
Conclusion: The Molecule Without a Purpose
The popular version of this story is that the pineal gland releases a flood of DMT at the moment of death, and that this is what people see when they die. The pharmacology does not support it. The gland is too small, the measured concentrations are orders of magnitude too low, and the production is not even confined to the pineal.
But the fact that started the whole line of inquiry has survived every correction, and it is the strangest part:
Your neurons contain the enzymatic machinery to manufacture one of the most powerful psychedelics known, and they are doing it right now, in small amounts, for no reason anyone has identified.
A synthetic pathway that does nothing is expensive to keep, and bodies do not generally carry expensive machinery for no reason. The machinery is conserved across mammals, which normally indicates function.
We have found the factory, confirmed it is running, and have no idea what it makes the product for. That is a considerably better mystery than the one it gets replaced with.
Continue Reading
- Near-Death Experiences: The Brain Spikes, It Does Not Fade — EEG flatlines 20 seconds after cardiac arrest. So why do 10-20% of survivors report structured, vivid experiences – and…
- Lucid Dreaming: The Message Sent From Inside a Dream — In 1975 a sleeping man moved his eyes in a pre-agreed pattern and proved lucid dreaming is real. What the brain does…
- The Pineal Gland: The Eye That Went Inside — Some lizards have a real third eye with a lens and a retina, and it is an extension of the pineal. What the human…